These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10568510)

  • 1. Synuclein expression is decreased in rat substantia nigra following induction of apoptosis by intrastriatal 6-hydroxydopamine.
    Kholodilov NG; Oo TF; Burke RE
    Neurosci Lett; 1999 Nov; 275(2):105-8. PubMed ID: 10568510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury.
    Kholodilov NG; Neystat M; Oo TF; Lo SE; Larsen KE; Sulzer D; Burke RE
    J Neurochem; 1999 Dec; 73(6):2586-99. PubMed ID: 10582622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Hydroxydopamine lesioning differentially affects alpha-synuclein mRNA expression in the nucleus accumbens, striatum and substantia nigra of adult rats.
    Zeng BY; Dass B; Owen A; Rose S; Cannizzaro C; Tel BC; Jenner P
    Neurosci Lett; 2002 Mar; 322(1):33-6. PubMed ID: 11958837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra.
    Jeon BS; Kholodilov NG; Oo TF; Kim SY; Tomaselli KJ; Srinivasan A; Stefanis L; Burke RE
    J Neurochem; 1999 Jul; 73(1):322-33. PubMed ID: 10386985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid increase of Nurr1 expression in the substantia nigra after 6-hydroxydopamine lesion in the striatum of the rat.
    Ojeda V; Fuentealba JA; Galleguillos D; Andrés ME
    J Neurosci Res; 2003 Sep; 73(5):686-97. PubMed ID: 12929136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.
    Vila M; Vukosavic S; Jackson-Lewis V; Neystat M; Jakowec M; Przedborski S
    J Neurochem; 2000 Feb; 74(2):721-9. PubMed ID: 10646524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism.
    Silva RM; Ries V; Oo TF; Yarygina O; Jackson-Lewis V; Ryu EJ; Lu PD; Marciniak SJ; Ron D; Przedborski S; Kholodilov N; Greene LA; Burke RE
    J Neurochem; 2005 Nov; 95(4):974-86. PubMed ID: 16135078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells.
    Zhou W; Hurlbert MS; Schaack J; Prasad KN; Freed CR
    Brain Res; 2000 Jun; 866(1-2):33-43. PubMed ID: 10825478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intrastriatal injection of thrombin in rat induced a retrograde apoptotic degeneration of nigral dopaminergic neurons through synaptic elimination.
    Herrera AJ; de Pablos RM; Carreño-Müller E; Villarán RF; Venero JL; Tomás-Camardiel M; Cano J; Machado A
    J Neurochem; 2008 May; 105(3):750-62. PubMed ID: 18179476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of cytosolic branched chain aminotransferase in substantia nigra following developmental striatal target injury.
    Kholodilov NG; Neystat M; Oo TF; Hutson SM; Burke RE
    Brain Res Mol Brain Res; 2000 Feb; 75(2):281-6. PubMed ID: 10686349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cyclin-dependent kinase 5 and its activator p35 in models of induced apoptotic death in neurons of the substantia nigra in vivo.
    Neystat M; Rzhetskaya M; Oo TF; Kholodilov N; Yarygina O; Wilson A; El-Khodor BF; Burke RE
    J Neurochem; 2001 Jun; 77(6):1611-25. PubMed ID: 11413244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injury induced c-Jun expression and phosphorylation in the dopaminergic nigral neurons of the rat: correlation with neuronal death and modulation by glial-cell-line-derived neurotrophic factor.
    Vaudano E; Rosenblad C; Björklund A
    Eur J Neurosci; 2001 Jan; 13(1):1-14. PubMed ID: 11134999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra.
    Ichitani Y; Okamura H; Nakahara D; Nagatsu I; Ibata Y
    Exp Neurol; 1994 Dec; 130(2):269-78. PubMed ID: 7867756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-Hydroxydopamine increases the level of TNFalpha and bax mRNA in the striatum and induces apoptosis of dopaminergic neurons in hemiparkinsonian rats.
    Mladenović A; Perović M; Raicević N; Kanazir S; Rakić L; Ruzdijić S
    Brain Res; 2004 Jan; 996(2):237-45. PubMed ID: 14697501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons.
    Rideout HJ; Dietrich P; Savalle M; Dauer WT; Stefanis L
    J Neurochem; 2003 Feb; 84(4):803-13. PubMed ID: 12562524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and comparative analysis of differentially expressed proteins in rat striatum following 6-hydroxydopamine lesions of the nigrostriatal pathway: up-regulation of amyloid precursor-like protein 2 expression.
    Shen Y; Yu Y; Guo H; Tang Z; Yu FS; Zhou J
    Eur J Neurosci; 2002 Sep; 16(5):896-906. PubMed ID: 12372026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postnatal expression of alpha-synuclein protein in the rodent substantia nigra and striatum.
    Jakowec MW; Donaldson DM; Barba J; Petzinger GM
    Dev Neurosci; 2001; 23(2):91-9. PubMed ID: 11509831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered melatonin MT
    Kang NH; Carriere CH; Bahna SG; Niles LP
    Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of nigral dopaminergic neuron-enriched genes in adult rats.
    Zhou Q; Li J; Wang H; Yin Y; Zhou J
    Neurobiol Aging; 2011 Feb; 32(2):313-26. PubMed ID: 19303663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.